|4Feb 24, 6:11 PM ET

Sagent Pharmaceuticals, Inc. 4

4 · Sagent Pharmaceuticals, Inc. · Filed Feb 24, 2015

Insider Transaction Report

Form 4
Period: 2015-02-21
Drake Lorin
VP, Sales and Marketing
Transactions
  • Tax Payment

    Common Stock

    2015-02-22$28.50/sh293$8,35124,219 total
  • Tax Payment

    Common Stock

    2015-02-21$28.50/sh449$12,79724,512 total

Documents

1 file
  • 4
    rrd422816.xmlPrimary